Search
Close
Search
Advanced Search
Search Menu
AI Discovery Assistant

Extract

Objective

Up to today, no standardized treatment algorithm for Peyroniés Disease (PD) has been published. Based on this, the aim was to learn about the current PD management strategies applied by Sexual Medicine experts across Europe

Methods

Sexual Medicine experts across Europe - mostly urologists with the majority of them being members of the European Society for Sexual Medicine (ESSM) - were contacted and asked to fill in an online questionnaire, consisting of 56 items and developed by the Educational committee of the ESSM. In the end, 401 filled in the survey of which 277 reported treating PD themselves.

Results

78.1% of respondents were male with the majority (77.9%) specialized in Urology. 83.2% followed a specific diagnostic program, with 82.9% using questionnaires such as the International Index of Erectile Function (64.6%). The variety of treatment options used will be reported. With respect to intralesional therapy, collagenase was the leading substance (33.6%), followed by calcium channel blockers (16.%). Almost half of collagenase prescribers were satisfied (45.6%) or very satisfied (4.6%) with the treatment outcomes, whereas 37.6% were neither satisfied nor dissatisfied and 12.8% were dissatisfied or very dissatisfied. 184 respondents stated not using collagenase with nearly half of them saying that the costs are too high. Of the 36.3% applying extracorporal shock-wave therapy (ESWT). 41.1% used ESWT only in calcified plaques. 95% of respondents recommended surgical procedures regularly and 73.9% performed surgery personally. The preferred surgical procedure was Nesbit (32.8%), followed by tunica plication (27.2%). Almost two thirds indicated involving the partner in the decision-making process of which therapy form to use (60.2%).

Issue Section:
HP-09 Male Sexual Dysfuntion: IPP
You do not currently have access to this article.
Download all slides